CD8A and cancer: When CD8-positive cytotoxic T lymphocytes (CTLs) recognize these neoantigens presented on the MHC molecules, the CTLs are activated and proliferate, leading to an antigen-specific immune response that kills neoantigen-bearing cancer cells [13, 14].